Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001493152-21-012357

Options or other derivatives

  • Chief Financial Officer bought 30,000 shares at an average $0.31 ($9,420)

From the SEC's structured data for this filing

Trades in this filing

Arrow Alexander K. · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-18 Purchase : show line 1 in the form PTIXW Common Stock 5-year warrants strike price $4.98 +12,000 $0.32 $3,840 12,000 D
2021-05-18 Purchase : show line 2 in the form PTIXW Common Stock 5-year warrants strike price $4.98 +18,000 $0.31 $5,580 30,000 D
Loading xslF345X03/ownership.xml…